1. Home
  2. SER vs GAIA Comparison

SER vs GAIA Comparison

Compare SER & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.60

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$1.65

Market Cap

37.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SER
GAIA
Founded
2017
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
37.1M
IPO Year
2024
1999

Fundamental Metrics

Financial Performance
Metric
SER
GAIA
Price
$2.60
$1.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$15.00
$6.50
AVG Volume (30 Days)
58.2K
158.3K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.18
EPS
N/A
N/A
Revenue
$130,000.00
$4,500,000.00
Revenue This Year
N/A
$13.07
Revenue Next Year
N/A
$12.04
P/E Ratio
N/A
N/A
Revenue Growth
132.14
12.50
52 Week Low
$1.22
$1.16
52 Week High
$5.83
$6.39

Technical Indicators

Market Signals
Indicator
SER
GAIA
Relative Strength Index (RSI) 56.37 49.17
Support Level $1.69 $1.16
Resistance Level $2.95 $2.01
Average True Range (ATR) 0.19 0.10
MACD -0.03 0.04
Stochastic Oscillator 51.29 69.70

Price Performance

Historical Comparison
SER
GAIA

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: